Unique ID issued by UMIN | UMIN000002819 |
---|---|
Receipt number | R000002135 |
Scientific Title | Efficacy and safety of Clarithromycin(CAM)/Ethambutol(EB) versus Rifampicin(RIF)/Clarithromycin(CAM)/Ethambutol(EB) in Mycobacterium avium Complex(MAC): a randomized, open-label, multicenter study |
Date of disclosure of the study information | 2009/12/01 |
Last modified on | 2012/05/01 15:15:00 |
Efficacy and safety of Clarithromycin(CAM)/Ethambutol(EB) versus Rifampicin(RIF)/Clarithromycin(CAM)/Ethambutol(EB) in Mycobacterium avium Complex(MAC): a randomized, open-label, multicenter study
Efficacy and safety of Clarithromycin(CAM)/Ethambutol(EB) versus Rifampicin(RIF)/Clarithromycin(CAM)/Ethambutol(EB) in Mycobacterium avium Complex(MAC): a randomized, open-label, multicenter study
Efficacy and safety of Clarithromycin(CAM)/Ethambutol(EB) versus Rifampicin(RIF)/Clarithromycin(CAM)/Ethambutol(EB) in Mycobacterium avium Complex(MAC): a randomized, open-label, multicenter study
Efficacy and safety of Clarithromycin(CAM)/Ethambutol(EB) versus Rifampicin(RIF)/Clarithromycin(CAM)/Ethambutol(EB) in Mycobacterium avium Complex(MAC): a randomized, open-label, multicenter study
Japan |
Mycobacterium avium Complex(MAC) without HIV
Pneumology |
Others
NO
Evaluation of efficacy and safety of Clarithromycin/Ethambutol for Mycobacterium avium Complex(MAC).
PK,PD
Confirmatory
Pragmatic
Not applicable
chest Xray, HRCT, bacteriologic evaluation, clinical symptom
the serum and intracellular concentration of Clarithromycin, Clarithromycin resistance of MAC
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Medicine |
Body weight is over 40kg.
Rifampicin 450mg/day
Clarithromycin 600mg/day
Ethambutol 750mg/day
Body weight is under 40kg.
Rifampicin 300mg/day
Clarithromycin 400mg/day
Ethambutol 500mg/day
Duration
One year.
Body weight is over 40kg.
Clarithromycin 600mg/day
Ethambutol 750mg/day
Body weight is under 40kg.
Clarithromycin 400mg/day
Ethambutol 500mg/day
Duration
One year.
20 | years-old | <= |
Not applicable |
Male and Female
Meeting diagnostic criteria for MAC infection described in "Am J Respir Crit Care Med Vol.175. p367-416".
Written informed consent obtained.
ECOG performance status 3-4.
Patients with HIV infection.
Patients with history of treatment for MAC infection.
Patients with any undelying disease considered tohave a significant impact on the course of treatment in this clinical study such as progressive cancer.
Patients receiving immunosuppressive drug.
100
1st name | |
Middle name | |
Last name | Kinngo Chida |
Hamamatsu University School of Medicine
Second Division, Department of Internal Medicine
1-20-1Handayama Hamamatu Japan
053-435-2354
1st name | |
Middle name | |
Last name | Masahiro shirai |
National hospital Organization Tenryu Hospital
respiratory medicine
4201-2 Oro Hamakitaku Hamamatsu Shizuoka Japan
053-583-3111
http://www.tenryu-hosp.jp/
shiraim@smail.plala.or.jp
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine
National hospital Organization Tenryu Hospital
Self funding
Japan
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine
NO
浜松医科大学第2内科(静岡県)
2009 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
2006 | Year | 04 | Month | 01 | Day |
2006 | Year | 04 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 04 | Month | 01 | Day |
2011 | Year | 04 | Month | 01 | Day |
2011 | Year | 05 | Month | 01 | Day |
2009 | Year | 12 | Month | 01 | Day |
2012 | Year | 05 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002135